Pharma IQ | 11/26/2010
Dr. Paul Matejtschuk Principal Scientist at NIBSC, joins Andrea Charles from Pharma IQ, to address the key challenges in optimal formulation development and how advances in freeze drying have impacted on formulation development. Matejtschuk also dicusses how can we utilise accelerated degradation studies to better predict product stability and what methods are the industry are employing to accelerate lyophilisation cycle development.
To continue reading this story Click Here
RECOMMENDED
The Trust Equation: Why Transparency Defines the Future Winners in Contract Manufacturing
2025-12-17
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More